DNAL1 and neoplasm: Another article reported the pre-clinical evaluation of a KK-LC-1 reactive T cell receptor (KK-LC-1 TCR), including in vitro tumor cell targeting, in vivo regression of xenograft tumors, cross-reactivity studies, and evaluation of the expression of healthy tissues and tumor antigens.